ESC Premium Access

Inclusion of echocardiographic measure of right ventricular function in the non-invasive French pulmonary arterial hypertension risk stratification method

Congress Session

About the speaker

Doctor Charles Fauvel

University Hospital of Rouen, Rouen (France)
0 follower

4 more presentations in this session

Non-invasive risk prediction based on right ventricular function in patients with pulmonary arterial hypertension

Speaker: Mrs V. Qaderi (Hamburg, DE)

Thumbnail

Twenty-year experience and outcomes in a national paediatric pulmonary hypertension service

Speaker: Doctor A. Constantine (London, GB)

Thumbnail

Safety, tolerability, and pharmacokinetics (PK) of treprostinil palmitil inhalation powder (TPIP): a phase 1, randomised, double-blind, single- and multiple-dose study

Speaker: Doctor F. Ismat (Bridgewater, US)

Thumbnail

Treatment effect of selexipag on time to disease progression when initiated early in pulmonary arterial hypertension (PAH) patients: GRIPHON and TRITON pooled analysis

Speaker: Doctor J. Coghlan (London, GB)

Thumbnail

Access the full session

Pulmonary arterial hypertension: risk stratification guides for new treatments and informed outcomes

Speakers: Doctor C. Fauvel, Mrs V. Qaderi, Doctor A. Constantine, Doctor F. Ismat, Doctor J. Coghlan
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

27 August 2021

ESC Premium Access

Impact of COVID-19 pandemics upon pulmonary hypertension patients: insights from BNP-PL national database

27 August 2021

ESC Premium Access

Heart failure as a complication of covid-19 infection: systematic review and meta-analysis

27 August 2021

This platform is supported by

logo Novo Nordisk